documents: FDA-2024-D-5601-0016
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-D-5601-0016 | FDA | FDA-2024-D-5601 | E6(R3) Good Clinical Practice: Annex 2; International Council for Harmonisation; Draft Guidance for Industry; Reopening of the Comment Period | Notice | Extension of Comment Period | 2025-03-13T04:00:00Z | 2025 | 3 | 2025-03-13T04:00:00Z | 2025-03-13T13:11:09Z | 2025-04026 | 0 | 0 | 09000064869e6d90 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref